{"id":"lipid-emulsions-intravenous","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Lipemia"},{"rate":null,"effect":"Phlebitis at infusion site"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Hepatic steatosis with prolonged use"},{"rate":null,"effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL3354642","moleculeType":"Small molecule","molecularWeight":"1826.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Intravenous lipid emulsions are oil-in-water emulsions containing triglycerides, phospholipids, and other lipid components that serve as a source of energy and essential fatty acids (linoleic and alpha-linolenic acid) for parenteral nutrition. They are administered as part of total parenteral nutrition (TPN) regimens to support metabolic needs, particularly in critically ill, post-operative, or malnourished patients who cannot tolerate enteral feeding.","oneSentence":"Lipid emulsions provide essential fatty acids and calories intravenously to patients unable to receive adequate nutrition orally or enterally.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:18.591Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition"},{"name":"Nutritional support in critically ill patients"},{"name":"Post-operative nutritional support"},{"name":"Severe malnutrition requiring intravenous feeding"}]},"trialDetails":[{"nctId":"NCT07470385","phase":"","title":"Effects of Lipid Emulsions on Coagulation","status":"COMPLETED","sponsor":"Mimi Tang, PhD","startDate":"2025-05-23","conditions":"Coagulation Disorder, Coagulation Function","enrollment":6259},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT06052956","phase":"PHASE2","title":"Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-07-15","conditions":"Abscess","enrollment":120},{"nctId":"NCT07025343","phase":"NA","title":"Does Intralipid Infusion Can Reverse the Spinal Anesthesia Effect in Day Case Surgery?","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-01","conditions":"Intralipid Infusion, Spinal Anesthesia, Day Case Surgery","enrollment":200},{"nctId":"NCT06049680","phase":"PHASE4","title":"Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients","status":"RECRUITING","sponsor":"Fresenius Kabi","startDate":"2024-10-28","conditions":"Malnutrition, Child, Malnutrition, Essential Fatty Acid Deficiency (EFAD)","enrollment":100},{"nctId":"NCT04584983","phase":"PHASE2","title":"Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-02-11","conditions":"Bilirubin Encephalopathy","enrollment":134},{"nctId":"NCT07162688","phase":"PHASE1, PHASE2","title":"Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.","status":"ENROLLING_BY_INVITATION","sponsor":"Fujian Medical University","startDate":"2025-05-16","conditions":"Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT02512718","phase":"PHASE1","title":"Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"Alexandra N. Carey","startDate":"2016-06","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":20},{"nctId":"NCT02412566","phase":"","title":"SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Baylor College of Medicine","startDate":"","conditions":"Cholestasis, Growth Failure","enrollment":""},{"nctId":"NCT03387579","phase":"PHASE3","title":"Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates","status":"COMPLETED","sponsor":"Indiana University","startDate":"2018-11-30","conditions":"Cholestasis of Parenteral Nutrition","enrollment":24},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT06988982","phase":"NA","title":"Lipid Emulsion for Reversal of Spinal Anesthesia in Ambulatory Surgery","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2025-06-01","conditions":"Spinal Anaesthesia, Spinal Anesthesia Evaluation, Ambulatory Surgery","enrollment":42},{"nctId":"NCT03949907","phase":"NA","title":"Early IntraVenous Administration of Nutritional Support","status":"TERMINATED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2020-04-14","conditions":"Cancer of Stomach, GastroEsophageal Cancer","enrollment":34},{"nctId":"NCT06934811","phase":"PHASE4","title":"Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wannan Medical College","startDate":"2025-05-01","conditions":"ECMO Treatment, ARDS (Acute Respiratory Distress Syndrome), ECMO and Acute MI","enrollment":30},{"nctId":"NCT03857646","phase":"PHASE4","title":"The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-03-02","conditions":"Prematurity","enrollment":66},{"nctId":"NCT01943409","phase":"PHASE4","title":"Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils","status":"COMPLETED","sponsor":"Johane Allard","startDate":"2013-07","conditions":"Obstruction, Cancer, Ileus","enrollment":303},{"nctId":"NCT03122886","phase":"NA","title":"Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-07-14","conditions":"Advanced Malignant Neoplasm","enrollment":19},{"nctId":"NCT05537389","phase":"NA","title":"Intravenous Neonatal Central Access Safety Trial","status":"RECRUITING","sponsor":"University of Turin, Italy","startDate":"2023-01-01","conditions":"Newborn Complication, Catheter Complications","enrollment":736},{"nctId":"NCT06316362","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT01143064","phase":"PHASE3","title":"Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury","status":"COMPLETED","sponsor":"BHR Pharma, LLC","startDate":"2010-06","conditions":"Brain Injuries","enrollment":1195},{"nctId":"NCT06559878","phase":"NA","title":"Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans","status":"ENROLLING_BY_INVITATION","sponsor":"Helsinki University Central Hospital","startDate":"2024-09-01","conditions":"Non-alcoholic Fatty Liver Disease NAFLD","enrollment":12},{"nctId":"NCT02534077","phase":"","title":"Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants","status":"APPROVED_FOR_MARKETING","sponsor":"Pediatrix","startDate":"","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT06413589","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT03107689","phase":"","title":"Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2012-05","conditions":"Overdose","enrollment":134},{"nctId":"NCT02328768","phase":"","title":"Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children","status":"APPROVED_FOR_MARKETING","sponsor":"University of Nebraska","startDate":"","conditions":"Total Parenteral Nutrition-Induced Cholestasis","enrollment":""},{"nctId":"NCT03693287","phase":"PHASE4","title":"Personalized vs Standardized PN for Preterm Infants >1250g","status":"UNKNOWN","sponsor":"Ospedali Riuniti Ancona","startDate":"2021-07-04","conditions":"Infant,Premature, Parenteral Nutrition, Growth","enrollment":150},{"nctId":"NCT05746013","phase":"NA","title":"Lipoproteins and ImmunoMetabolism","status":"UNKNOWN","sponsor":"University of Seville","startDate":"2020-02-01","conditions":"Obesity, Metabolic Syndrome, Metabolism Disorder","enrollment":40},{"nctId":"NCT03563222","phase":"PHASE4","title":"Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2019-12-18","conditions":"Malnutrition, Child","enrollment":1},{"nctId":"NCT01845116","phase":"PHASE2","title":"Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2010-07","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":11},{"nctId":"NCT04078906","phase":"NA","title":"SMOFlipid and Incidence of BPD in Preterm Infants","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2019-12-16","conditions":"Very Low Birth Weight Infant, Bronchopulmonary Dysplasia","enrollment":384},{"nctId":"NCT05006638","phase":"PHASE4","title":"Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity","status":"UNKNOWN","sponsor":"Aya Sabry Mohamed Mohamed","startDate":"2022-12","conditions":"Pesticide Poisoning","enrollment":62},{"nctId":"NCT05370729","phase":"NA","title":"Impact of N-acetylcysteine Infusion and Intralipid Infusion on Myocardial Injury in Aluminum Phosphide Toxicity","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-05","conditions":"Myocardial Injury","enrollment":58},{"nctId":"NCT02579265","phase":"PHASE3","title":"Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2015-12","conditions":"Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days","enrollment":204},{"nctId":"NCT03594474","phase":"NA","title":"Early Higher Intravenous Lipid Intake in VLBW Infants","status":"COMPLETED","sponsor":"Belal Alshaikh","startDate":"2018-08-15","conditions":"Very Low Birth Weight Infant","enrollment":83},{"nctId":"NCT05148611","phase":"","title":"Application Registration Study of ILE in Patients With Acute Poisoning","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2021-11-30","conditions":"Acute Poisoning","enrollment":500},{"nctId":"NCT04558190","phase":"NA","title":"Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2020-09-02","conditions":"Insulin Resistance","enrollment":10},{"nctId":"NCT04957940","phase":"PHASE3","title":"Lipid Emulsion Infusion and COVID-19 Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-07-05","conditions":"Covid19","enrollment":74},{"nctId":"NCT04951791","phase":"NA","title":"Lipid Emulsion in Cardiac Valve Replacement Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-08","conditions":"Ischemic Reperfusion Injury","enrollment":68},{"nctId":"NCT00738101","phase":"NA","title":"Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2008-09","conditions":"Cholestasis, Cholestasis of Parenteral Nutrition","enrollment":293},{"nctId":"NCT04807634","phase":"NA","title":"Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-03-10","conditions":"Coma","enrollment":30},{"nctId":"NCT04711564","phase":"","title":"The Effects of Different Lipid Emulsions on the Adipokines in Critically Ill Patients With Sepsis","status":"COMPLETED","sponsor":"Karadeniz Technical University","startDate":"2018-03-29","conditions":"Sepsis","enrollment":40},{"nctId":"NCT02357576","phase":"PHASE3","title":"Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2016-05-21","conditions":"Cholestasis","enrollment":22},{"nctId":"NCT00512629","phase":"PHASE1","title":"Cholestasis Prevention: Efficacy of IV Fish Oil","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2007-07","conditions":"Cholestasis, Parenteral Nutrition","enrollment":19},{"nctId":"NCT01555957","phase":"PHASE3","title":"Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2012-02","conditions":"Parenteral Nutrition Associated Cholestasis","enrollment":40},{"nctId":"NCT04437927","phase":"","title":"Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT","status":"COMPLETED","sponsor":"Centre Hospitalier Princesse Grace","startDate":"2020-04-07","conditions":"Metabolic Preparation, Myocardial Inflammation","enrollment":51},{"nctId":"NCT04586608","phase":"NA","title":"Investigation of Administration of MCT/ω-3 Fatty Acids is Towards Anti-inflammatory Related Fatty Acid Profile in Preterm Neonates.","status":"COMPLETED","sponsor":"Iaso Maternity Hospital, Athens, Greece","startDate":"2018-02-15","conditions":"Premature Birth","enrollment":92},{"nctId":"NCT04511299","phase":"NA","title":"Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2020-04-07","conditions":"Surgery","enrollment":12},{"nctId":"NCT04467138","phase":"","title":"High Dose Intravenous Fish Oil Reduces Inflammation","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2020-01-31","conditions":"Lipid Metabolism Disorders","enrollment":51},{"nctId":"NCT02609984","phase":"PHASE2","title":"Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)","status":"TERMINATED","sponsor":"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2015-04-29","conditions":"Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma","enrollment":89},{"nctId":"NCT01173159","phase":"NA","title":"Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2010-07","conditions":"Cholestasis","enrollment":10},{"nctId":"NCT04347902","phase":"PHASE4","title":"Lipid Emulsions and Liver Function - Results After 5 Years.","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2016-01","conditions":"Liver Failure, Parenteral Nutrition-Related Hepatitis","enrollment":65},{"nctId":"NCT02796833","phase":"PHASE4","title":"Comparison of Two Intravenous Lipid Emulsions in Home Parenteral Nutrition Patients","status":"COMPLETED","sponsor":"Johane Allard","startDate":"2016-03","conditions":"Home Parenteral Nutrition","enrollment":50},{"nctId":"NCT02370251","phase":"PHASE2, PHASE3","title":"Compassionate Use of Omegaven in Children","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2015-06","conditions":"Total Parenteral Nutrition-induced Cholestasis, Cholestasis, Short Bowel Syndrome","enrollment":63},{"nctId":"NCT03127345","phase":"PHASE2","title":"Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2019-09","conditions":"Esophageal Atresia","enrollment":""},{"nctId":"NCT03481894","phase":"PHASE4","title":"Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of Age","status":"WITHDRAWN","sponsor":"Fresenius Kabi","startDate":"2018-03","conditions":"Malnutrition","enrollment":""},{"nctId":"NCT01089426","phase":"NA","title":"Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury","status":"COMPLETED","sponsor":"Children's Hospital Los Angeles","startDate":"2008-09","conditions":"Liver Injury","enrollment":90},{"nctId":"NCT01412359","phase":"","title":"Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Jeffrey Rudolph","startDate":"","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT02780193","phase":"","title":"Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Rush University Medical Center","startDate":"","conditions":"Cholestasis, Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT02778698","phase":"","title":"Compassionate Use of Omegaven","status":"APPROVED_FOR_MARKETING","sponsor":"Geisinger Clinic","startDate":"","conditions":"Cholestasis","enrollment":""},{"nctId":"NCT01194063","phase":"PHASE3","title":"Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children","status":"COMPLETED","sponsor":"Kapiolani Medical Center For Women & Children","startDate":"2010-10-20","conditions":"Cholestasis","enrollment":36},{"nctId":"NCT01425567","phase":"","title":"Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"","conditions":"Liver Disease","enrollment":""},{"nctId":"NCT00672854","phase":"PHASE2, PHASE3","title":"Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-11","conditions":"Parenteral Nutrition","enrollment":100},{"nctId":"NCT00589888","phase":"NA","title":"FFA-Induced Hypertension and Endothelial Dysfunction","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-08","conditions":"Endothelial Dysfunction, Hypertension","enrollment":13},{"nctId":"NCT02691533","phase":"NA","title":"To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-02-01","conditions":"Chronic Liver Failure","enrollment":90},{"nctId":"NCT01325584","phase":"PHASE2","title":"Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury","status":"TERMINATED","sponsor":"Midwestern Regional Medical Center","startDate":"2012-10","conditions":"Cancer, Hepatic Injury","enrollment":12},{"nctId":"NCT03564574","phase":"PHASE4","title":"To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2015-09","conditions":"Organophosphate Poisoning","enrollment":40},{"nctId":"NCT01520454","phase":"NA","title":"Effect of Increased Free Fatty Acids on Leptin Function","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2011-11","conditions":"Obesity, Leptin Resistance","enrollment":26},{"nctId":"NCT02722902","phase":"NA","title":"Carnitine Infusion and Insulin Resistance","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2016-05","conditions":"Glucose Intolerance","enrollment":17},{"nctId":"NCT03275090","phase":"PHASE4","title":"The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis","status":"COMPLETED","sponsor":"Mansoura University Children Hospital","startDate":"2016-02-01","conditions":"Sepsis Newborn","enrollment":40},{"nctId":"NCT02550860","phase":"PHASE3","title":"Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2015-01","conditions":"Intestinal Diseases","enrollment":13},{"nctId":"NCT03442361","phase":"","title":"Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2012-07-01","conditions":"Parenteral Nutrition Associated Liver Disease","enrollment":206},{"nctId":"NCT02807727","phase":"PHASE2, PHASE3","title":"Cardiac REperfusion With Intralipid® at Reperfusion","status":"UNKNOWN","sponsor":"Nkanyiso Hadebe","startDate":"2017-01","conditions":"Reperfusion Injury","enrollment":30},{"nctId":"NCT02762539","phase":"NA","title":"Omega3 PUFA in Head Trauam","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2016-06","conditions":"Traumatic Brain Injury","enrollment":70},{"nctId":"NCT00158769","phase":"PHASE1","title":"A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-03-31","conditions":"Sepsis","enrollment":16},{"nctId":"NCT02633384","phase":"PHASE4","title":"Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions","status":"TERMINATED","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2011-08","conditions":"Intrahepatic, Cholestasis","enrollment":52},{"nctId":"NCT02721277","phase":"PHASE1, PHASE2","title":"SMOFlipid to Lessen the Severity of Neonatal Cholestasis","status":"TERMINATED","sponsor":"University of Florida","startDate":"2016-05","conditions":"Cholestasis, Jaundice, Obstructive","enrollment":2},{"nctId":"NCT02924454","phase":"PHASE4","title":"Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.","status":"COMPLETED","sponsor":"Mikkel Bring Christensen","startDate":"2016-09","conditions":"Drug Overdose, Overdose of Beta-adrenergic Blocking Drug, Blood Pressure","enrollment":10},{"nctId":"NCT03044639","phase":"PHASE4","title":"Parenteral Lipid Emulsions and the Liver Function","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2010-04-01","conditions":"Liver Failure","enrollment":64},{"nctId":"NCT02865486","phase":"NA","title":"Digestion of Biopolymer Based Lipid Emulsions","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2016-03","conditions":"Healthy","enrollment":21},{"nctId":"NCT01373918","phase":"PHASE4","title":"Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2010-12","conditions":"Cholestasis","enrollment":41},{"nctId":"NCT00516178","phase":"PHASE3","title":"Intravenous Fish Oil in Critically Ill Cardiac Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2008-01","conditions":"Coronary Artery Disease","enrollment":31},{"nctId":"NCT02349594","phase":"PHASE4","title":"Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2014-01","conditions":"Crohn Disease","enrollment":6},{"nctId":"NCT00534300","phase":"PHASE1, PHASE2","title":"Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2007-10","conditions":"Ventricular Tachycardia, Sudden Cardiac Death","enrollment":8},{"nctId":"NCT02226029","phase":"EARLY_PHASE1","title":"Quantitative MR Methods for Lipid Emulsions","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2014-08","conditions":"Healthy","enrollment":22},{"nctId":"NCT00330967","phase":"","title":"Mechanisms of Insulin Resistance in Humans","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2006-04","conditions":"Inflammation, Insulin Resistance","enrollment":25},{"nctId":"NCT01175330","phase":"PHASE3","title":"Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting","status":"TERMINATED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2010-08","conditions":"Ischemic Heart Disease, Atrial Fibrillation","enrollment":39},{"nctId":"NCT02185729","phase":"PHASE2, PHASE3","title":"Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-06","conditions":"Diseases, Metabolic, Insulin Sensitivity","enrollment":12},{"nctId":"NCT01096446","phase":"NA","title":"Intravenous Fat Emulsions and Premature Infants","status":"TERMINATED","sponsor":"OSF Healthcare System","startDate":"2008-04","conditions":"Hypertriglyceridemia, Hyperglycemia","enrollment":19},{"nctId":"NCT01050660","phase":"NA","title":"Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates","status":"COMPLETED","sponsor":"Yale University","startDate":"2009-06","conditions":"Parenteral Nutrition-Associated Liver Disease","enrollment":136},{"nctId":"NCT00666328","phase":"PHASE3","title":"Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2008-06","conditions":"Hypertension, Hemorrhage","enrollment":37},{"nctId":"NCT00803634","phase":"PHASE3","title":"Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2008-12","conditions":"Hypertension, Heart Failure","enrollment":117},{"nctId":"NCT00093249","phase":"PHASE3","title":"Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2004-01","conditions":"Hypertension","enrollment":105},{"nctId":"NCT01692834","phase":"PHASE1","title":"A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers","status":"COMPLETED","sponsor":"NeuroVive Pharmaceutical AB","startDate":"2009-06","conditions":"Healthy","enrollment":65},{"nctId":"NCT01096771","phase":"PHASE2","title":"The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)","status":"TERMINATED","sponsor":"Methodist Research Institute, Indianapolis","startDate":"2010-06","conditions":"Acute Respiratory Distress Syndrome","enrollment":14},{"nctId":"NCT00369837","phase":"PHASE3","title":"Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2006-09","conditions":"Hypertension","enrollment":131},{"nctId":"NCT00396461","phase":"PHASE4","title":"ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients","status":"TERMINATED","sponsor":"B. Braun Medical SA","startDate":"2006-11","conditions":"Critical Illness","enrollment":212},{"nctId":"NCT00793195","phase":"PHASE2","title":"Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?","status":"UNKNOWN","sponsor":"The Hospital for Sick Children","startDate":"2009-01","conditions":"Short Bowel Syndrome, Intestinal Failure, Gastrointestinal Motility Disorder","enrollment":24},{"nctId":"NCT00259025","phase":"PHASE2","title":"Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2006-09","conditions":"Renal Failure, Chronic","enrollment":60},{"nctId":"NCT00708266","phase":"NA","title":"The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2007-02","conditions":"Obesity, Type 2 Diabetes Mellitus","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["parenteral lipid provision"],"phase":"marketed","status":"active","brandName":"Lipid Emulsions, Intravenous","genericName":"Lipid Emulsions, Intravenous","companyName":"Stanley Dudrick's Memorial Hospital","companyId":"stanley-dudrick-s-memorial-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipid emulsions provide essential fatty acids and calories intravenously to patients unable to receive adequate nutrition orally or enterally. Used for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Nutritional support in critically ill patients, Post-operative nutritional support.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}